Method for performing CASP3 gene knockout on mesenchymal stem cell through CRISPR-CAS system
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 天津金匙医学科技有限公司
- Publication Date
- 2018-01-16
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention provides a CRISPR-cas system for performing CASP3 gene editing on mesenchymal stem cells, and in particular relates to the establishment of a CASP3 gene knockout mesenchymal stem cell line. Background technique
[0002] Mesenchymal stem cells (MSCs) are adult stem cells with self-replication ability and multi-directional differentiation potential, which can develop into bone, cartilage, fat and other types of cells. Mesenchymal stem cells can be transplanted, and the type of cells they grow into depends on where they are injected. For example, mesenchymal stem cells injected into the heart can form healthy new tissue, among other things.
[0003] Mesenchymal stem cells (MSCs) are a type of pluripotent stem cells derived from the mesoderm and ectoderm in early development. Mainly exist in connective tissue and interstitium of organs, and the content is most abundant in bone marrow tissue. Since bone marrow is its main source, the...